Arif Khan, MD

Northwest Clinical Research Center, Bellevue, Washington

  • 12Articles
  • 38KReads
  • 2001–2026Active
  • 59Collaborators
  • 107Citations

About

Arif Khan, MD, is affiliated with the Northwest Clinical Research Center in Bellevue, Washington. With publications spanning from 2001 to 2026, Khan has contributed to 12 articles on topics including depression, anxiety, bipolar disorder, panic disorder, psychiatry, somatoform disorders, and weight. Frequent co-authors include Donald S. Robinson, Michael E. Thase, Seth Cohen, Shirin Khan, and Adam Ruth.

Publications

PCC
Bupropion-Dextromethorphan for Clinically Challenging Apathy
Case Report

Bupropion-Dextromethorphan for Clinically Challenging Apathy

April 2, 2026

This case shows potential benefits of glutamate system–activating medication in addressing clinically challenging apathy in a 44-year-old man with depression.
, , , et al
PCC
Article

Vilazodone and Psychic and Somatic Anxiety

April 28, 2016

Is the SSRI vilazodone effective for treating generalized anxiety disorder? To comprehensively evaluate the effect of vilazodone across the range of anxiety symptoms associated with the disorder, Khan and...
, , , et al
JCP
Original Research

A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder

April 15, 2011

, , , et al
JCP
ASCP Corner

Is the Problem of a High Placebo Response Unique to Antidepressant Trials?

December 31, 2008

,
JCP
Original Research

The History and Current State of Antidepressant Clinical Trial Design: A Call to Action for Proof-of-Concept Studies

October 31, 2008

, , , et al
JCP
ASCP Corner

Are Antidepressants Effective? What's a Clinician to Think?

June 30, 2008

, ,
JCP
Original Research

Mortality Risk in Patients With Schizophrenia Participating in Premarketing Atypical Antipsychotic Clinical Trials

December 14, 2007

, , , et al
JCP
Original Research

The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

June 15, 2007

, , , et al
JCP
Original Research

Relapse Prevention of Panic Disorder in Adult Outpatient Responders to Treatment With Venlafaxine Extended Release

January 15, 2007

, , , et al
JCP
Original Research

The Effect of a Switch to Ziprasidone in an Adult Population With Autistic Disorder: Chart Review of Naturalistic, Open-Label Treatment

January 1, 2004

, , , et al
JCP
Original Research

Weight, Lipids, Glucose, and Behavioral Measures With Ziprasidone Treatment in a Population With Mental Retardation

January 15, 2003

, , , et al
JCP
Original Research

Weight Gain With Risperidone Among Patients With Mental Retardation: Effect of Calorie Restriction

February 2, 2001

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe